The Bio Report

Programing Cells in a Predictable and Scalable Way

02.21.2024 - By Levine Media GroupPlay

Download our free app to listen on your phone

Download on the App StoreGet it on Google Play

Mark Kotter, founder and CEO of Bit.Bio, discusses the company’s platform technology, its effort to develop cell therapies, and its growing offering of precision reprogramed human cells for drug development.

More episodes from The Bio Report